Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased activity of PIK3CA protein | decreases activity | 16179367
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in increased expression of PIK3CA mRNA | increases expression | 18648102
|
D000255 |
Adenosine Triphosphate |
Adenosine Triphosphate inhibits the reaction [resveratrol results in decreased activity of [PIK3R1 protein binds to PIK3CA protein]] | affects binding|decreases activity|decreases reaction | 17550345
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of PIK3CA mRNA | affects expression | 16483693
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of PIK3CA mRNA | decreases expression | 20458559
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PIK3CA mRNA | decreases expression | 20018196
|
C107676 |
deguelin |
deguelin metabolite results in decreased expression of PIK3CA protein | decreases expression | 19139008
|
C107676 |
deguelin |
deguelin results in decreased expression of PIK3CA protein | decreases expression | 19139008
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of PIK3CA mRNA | increases expression | 16002434
|
D004958 |
Estradiol |
Estradiol results in increased expression of PIK3CA mRNA | increases expression | 16029874
|
D006820 |
Hyaluronic Acid |
Hyaluronic Acid results in increased phosphorylation of PIK3CA protein | increases phosphorylation | 16864594
|
D018021 |
Lithium Chloride |
PIK3CA protein affects the reaction [Lithium Chloride results in increased phosphorylation of and results in decreased activity of GSK3B protein] | affects reaction|decreases activity|increases phosphorylation | 19196980
|
D018021 |
Lithium Chloride |
PIK3CA protein affects the susceptibility to Lithium Chloride | affects response to substance | 19196980
|
D018021 |
Lithium Chloride |
PIK3CA protein mutant form results in increased susceptibility to Lithium Chloride | increases response to substance | 19196980
|
D008713 |
Methimazole |
Methimazole results in increased expression of PIK3CA mRNA | increases expression | 17399805
|
C494474 |
perchlorate |
perchlorate results in increased expression of PIK3CA mRNA | increases expression | 17399805
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in decreased expression of PIK3CA mRNA | decreases expression | 16221955
|
D011441 |
Propylthiouracil |
Propylthiouracil results in increased expression of PIK3CA mRNA | increases expression | 17399805
|
C059514 |
resveratrol |
Adenosine Triphosphate inhibits the reaction [resveratrol results in decreased activity of [PIK3R1 protein binds to PIK3CA protein]] | affects binding|decreases activity|decreases reaction | 17550345
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [PIK3CA protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17550345
|
C059514 |
resveratrol |
resveratrol results in decreased activity of [PIK3R1 protein binds to PIK3CA protein] | affects binding|decreases activity | 17550345
|
C417521 |
SB 216763 |
PIK3CA protein affects the reaction [SB 216763 results in increased phosphorylation of and results in decreased activity of GSK3B protein] | affects reaction|decreases activity|increases phosphorylation | 19196980
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of PIK3CA mRNA | increases expression | 12016162
|
D014284 |
Triiodothyronine |
Triiodothyronine results in increased expression of PIK3CA mRNA | increases expression | 17403546
|
D013974 |
Thyroxine |
Thyroxine results in decreased expression of PIK3CA mRNA | decreases expression | 17403546
|
D013629 |
Tamoxifen |
PIK3CA gene mutant form affects the susceptibility to Tamoxifen | affects response to substance | 20479250
|
D013752 |
Tetracycline |
Tetracycline results in increased expression of PIK3CA mRNA | increases expression | 16917069
|
D014028 |
Tobacco Smoke Pollution |
Tobacco Smoke Pollution results in increased expression of PIK3CA mRNA | increases expression | 18087596
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.40 | 14745880 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.41 | 18287403 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.71 | 16538975 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
4.26 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.26 | 11473722 |
MESH:D002282 |
Adenocarcinoma, Bronchiolo-Alveolar |
|
Tobacco Smoke Pollution |
5.38 | 15814487 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
6.55 | 3712494 |
MESH:D000236 |
Adenoma |
|
resveratrol |
6.55 | 15688382 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.55 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.75 | 16712894 17306315 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
2.54 | 16183991 16162502 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
3.41 | 17115116 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tobacco Smoke Pollution |
3.15 | 19898480 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
3.18 | 17967414 16873680 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.87 | 1440618 11289319 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
8.95 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Propylthiouracil |
8.95 | 19483382 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
4.13 | 17600658 |
MESH:D001943 |
Breast Neoplasms |
marker/mechanism |
|
| 19685490 20479250 19196980 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
2.33 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
deguelin |
2.33 | 18593368 17035597 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.33 | 12948864 16675129 17289903 14630087 18497071 17261762 19861407 17018787 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
2.33 | 16393696 17534123 17651959 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
2.33 | 19189210 18821012 19103187 20005174 19410462 15565566 21138602 20544844 21152245 18351453 19059307 20065188 20390343 18855134 20859285 15668708 18815881 19155303 17242785 18629630 17261762 19142967 19011961 11161223 19288272 16818667 19200415 18984771 19084267 19115204 19244106 19066611 17893378 19289846 19487384 16202921 19189212 18997820 17049068 18425577 19221464 20135344 17440819 16873071 16273361 |
OMIM:604370 |
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1 |
marker/mechanism |
|
| |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.19 | 11589617 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.31 | 16111702 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.35 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
marker/mechanism |
|
| |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
13.72 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
13.72 | 14691202 16217749 15073043 15553829 11135700 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
deguelin |
13.72 | 18575727 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
13.72 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
13.72 | 19321006 16227395 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
13.72 | 15276417 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
13.72 | 16924424 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.44 | 16675471 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Tobacco Smoke Pollution |
3.37 | 11212258 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.72 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.61 | 7296757 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.98 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
10.51 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
10.51 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
10.51 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tobacco Smoke Pollution |
10.51 | 11212258 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.48 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Thyroxine |
4.02 | 18093424 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
3.37 | 15458977 |
MESH:D002386 |
Cataract |
|
Adenosine Triphosphate |
4.52 | 15003327 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
15.17 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
15.17 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
15.17 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
15.17 | 20056578 19524636 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
3.04 | 19486331 9022650 |
MESH:D003092 |
Colitis |
|
resveratrol |
3.98 | 16474422 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
2.43 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
marker/mechanism |
|
| |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
2.59 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
2.59 | 16550006 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.66 | 16507316 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.04 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
1.87 | 10525206 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.95 | 15213294 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.21 | 19031437 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.66 | 8156756 18759878 2524372 8970840 12868966 11298694 14531868 11906362 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.35 | 2952479 3621924 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.64 | 16873680 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
14.28 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
14.28 | 16286809 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
14.28 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
4.06 | 6482804 18289764 1440618 9328219 6679447 7440962 9653073 8291058 11289319 18648102 18692083 9022650 16192314 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetracycline |
4.06 | 17522070 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
6.85 | 12083418 17259670 |
MESH:D004487 |
Edema |
|
resveratrol |
6.85 | 8985016 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
14.60 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
14.60 | 17872969 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
14.60 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
7.06 | 18566989 11473722 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
7.06 | 16202921 19155303 17893378 20544844 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.70 | 17923197 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
6.99 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
6.99 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
6.99 | 12903497 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
12.48 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
12.48 | 14986274 19224547 |
MESH:D005234 |
Fatty Liver |
|
Tetracycline |
12.48 | 19224547 16917069 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.14 | 16709447 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.87 | 6705139 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.38 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.03 | 19069698 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.11 | 16904648 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.53 | 16452187 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
11.00 | 7505956 |
MESH:D006042 |
Goiter |
|
perchlorate |
11.00 | 18801409 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.37 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
3.95 | 3609246 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.88 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
4.03 | 16876885 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.03 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.60 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Lithium Chloride |
5.87 | 19797860 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
3.73 | 12083418 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
3.87 | 17188708 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
3.89 | 16873680 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.79 | 15034207 |
MESH:D006980 |
Hyperthyroidism |
|
Methimazole |
5.47 | 14678291 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.17 | 17488730 |
MESH:D007037 |
Hypothyroidism |
|
Methimazole |
11.45 | 18031379 |
MESH:D007037 |
Hypothyroidism |
|
Propylthiouracil |
11.45 | 18031379 8137927 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.50 | 17600658 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
2.89 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
11.43 | 12083418 |
MESH:D007249 |
Inflammation |
|
resveratrol |
11.43 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
11.43 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tobacco Smoke Pollution |
11.43 | 18590791 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.39 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.87 | 16627594 16393666 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.87 | 8074119 9022650 |
MESH:D017492 |
Keratosis, Seborrheic |
marker/mechanism |
|
| |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
5.82 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
5.82 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
11.69 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
11.69 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
11.69 | 18625569 |
MESH:D007938 |
Leukemia |
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
6.47 | 12970779 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
6.47 | 15070760 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.66 | 17077332 12560223 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.15 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.32 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
3.62 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
2.11 | 19850784 16467208 20471514 16968895 17050201 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
7.46 | 19642359 15336539 11468182 17869043 9834237 12679006 16330433 16823087 17107899 11161223 16112521 17217047 19035177 15213294 19075265 16966277 12712474 15622746 17712046 12018890 19225113 15748426 17649720 16331271 16891316 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
7.46 | 16087638 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.20 | 16882451 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
5.08 | 8812269 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.05 | 15342952 17567588 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.10 | 9327722 15034207 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
2.40 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
2.40 | 18564211 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
13.66 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
13.66 | 18709148 14757943 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
13.66 | 20405173 19812893 19321006 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
13.66 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
13.66 | 16684651 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
5.65 | 3712494 598648 1399818 6587162 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
5.65 | 20377131 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.23 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.07 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
marker/mechanism |
|
| |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
6.44 | 19825857 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
deguelin |
6.44 | 16288123 19336726 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
6.44 | 16712894 17077188 17306315 15276417 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
6.44 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tobacco Smoke Pollution |
6.44 | 12111688 3440675 16288123 11091918 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.16 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.75 | 14749477 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
9.49 | 15688416 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
9.49 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
9.44 | 16891317 11408345 17203775 11807958 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
9.44 | 8985016 11606380 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
9.44 | 14580682 16827153 19196722 19196723 11731420 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
12.14 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
12.14 | 19453300 |
MESH:D008545 |
Melanoma |
|
resveratrol |
4.99 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
4.99 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
4.99 | 12393984 19393235 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.03 | 15990972 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.24 | 17112576 |
MESH:D009062 |
Mouth Neoplasms |
|
Tobacco Smoke Pollution |
4.23 | 15006635 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
7.06 | 11468182 14977855 19417148 19549372 15949261 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
7.06 | 16490592 17935668 16267019 17049120 14749477 17164350 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.72 | 17962980 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.52 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
3.06 | 16882451 16105982 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
6.47 | 16525036 17125593 17188708 16456233 17015251 16317513 |
MESH:D009203 |
Myocardial Infarction |
|
SB 216763 |
6.47 | 16288908 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
3.89 | 17015251 17125593 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.16 | 16810080 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.61 | 17322642 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.81 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
5.49 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
5.49 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.47 | 19410462 |
MESH:D009369 |
Neoplasms |
|
deguelin |
5.45 | 17764071 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
5.45 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
8.73 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
8.73 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.85 | 19200415 19189210 19196722 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.58 | 17289903 |
MESH:D009395 |
Nephritis, Interstitial |
|
Tetracycline |
4.63 | 9884423 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
3.50 | 16427766 11399458 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
11.57 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
11.57 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
11.57 | 12854658 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
3.68 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.26 | 17929310 |
OMIM:162900 |
NEVUS, EPIDERMAL |
marker/mechanism |
|
| |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
4.80 | 9802331 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
3.29 | 6482804 4026338 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.87 | 3988306 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
4.11 | 17513867 |
MESH:D010051 |
Ovarian Neoplasms |
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
10.95 | 16211241 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
10.95 | 16624393 19769630 12452020 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
10.95 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
10.95 | 17306315 15276417 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
2.47 | 15580305 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.33 | 7296757 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.02 | 19927285 |
MESH:D010391 |
Pemphigoid, Bullous |
|
Tetracycline |
5.28 | 11026799 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.32 | 6228378 |
MESH:D011141 |
Polyuria |
|
Lithium Chloride |
5.85 | 19692487 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
9.53 | 17132714 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
9.53 | 16679765 |
MESH:D017096 |
Prion Diseases |
|
Tetracycline |
5.26 | 10903871 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.63 | 15572423 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.75 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
marker/mechanism |
|
| 17013881 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.08 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
2.08 | 15754350 16644109 18247401 16289102 12479363 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.08 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Hyaluronic Acid |
2.08 | 16864594 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.08 | 17718901 17804756 15767336 17675339 17636462 16731767 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.08 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.08 | 15067354 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.43 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
3.20 | 17520802 15827377 16314181 16317513 17058453 |
MESH:D012135 |
Respiratory Sounds |
|
Tobacco Smoke Pollution |
4.47 | 18410779 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.26 | 3692021 |
MESH:D012509 |
Sarcoma |
marker/mechanism |
|
| 20601955 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
3.81 | 16646077 |
MESH:D012878 |
Skin Neoplasms |
|
deguelin |
13.15 | 16041863 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
13.15 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
13.15 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tobacco Smoke Pollution |
13.15 | 18590791 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
4.14 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.89 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.68 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
marker/mechanism |
|
| |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
1.86 | 17007042 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.35 | 16321402 |
MESH:D013959 |
Thyroid Diseases |
|
Thyroxine |
5.49 | 19910387 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
11.38 | 6582329 7505956 1399818 3712494 6587162 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
11.38 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Propylthiouracil |
11.38 | 15710170 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.53 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
4.08 | 16227395 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.81 | 15213294 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
15.19 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
15.19 | 12973940 12845720 11780464 20435036 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
15.19 | 17306315 11723127 16712894 16452187 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
15.19 | 8653321 17572228 16712894 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tobacco Smoke Pollution |
15.19 | 12846360 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
9.12 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
9.12 | 11813266 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
3.99 | 17044934 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.27 | 17056641 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
4.15 | 17488730 |